JP2015042663A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015042663A5 JP2015042663A5 JP2014219074A JP2014219074A JP2015042663A5 JP 2015042663 A5 JP2015042663 A5 JP 2015042663A5 JP 2014219074 A JP2014219074 A JP 2014219074A JP 2014219074 A JP2014219074 A JP 2014219074A JP 2015042663 A5 JP2015042663 A5 JP 2015042663A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- hydrogen atom
- substituent
- optionally
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014219074A JP5891576B2 (ja) | 2011-03-31 | 2014-10-28 | 新規フラノン誘導体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011080185 | 2011-03-31 | ||
| JP2011080185 | 2011-03-31 | ||
| JP2014219074A JP5891576B2 (ja) | 2011-03-31 | 2014-10-28 | 新規フラノン誘導体 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013507805A Division JP5659356B2 (ja) | 2011-03-31 | 2012-03-30 | 新規フラノン誘導体 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016020407A Division JP6256927B2 (ja) | 2011-03-31 | 2016-02-05 | 新規フラノン誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015042663A JP2015042663A (ja) | 2015-03-05 |
| JP2015042663A5 true JP2015042663A5 (enExample) | 2015-04-30 |
| JP5891576B2 JP5891576B2 (ja) | 2016-03-23 |
Family
ID=46931496
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013507805A Active JP5659356B2 (ja) | 2011-03-31 | 2012-03-30 | 新規フラノン誘導体 |
| JP2014219074A Active JP5891576B2 (ja) | 2011-03-31 | 2014-10-28 | 新規フラノン誘導体 |
| JP2016020407A Active JP6256927B2 (ja) | 2011-03-31 | 2016-02-05 | 新規フラノン誘導体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013507805A Active JP5659356B2 (ja) | 2011-03-31 | 2012-03-30 | 新規フラノン誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016020407A Active JP6256927B2 (ja) | 2011-03-31 | 2016-02-05 | 新規フラノン誘導体 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US8742113B2 (enExample) |
| EP (1) | EP2692728B1 (enExample) |
| JP (3) | JP5659356B2 (enExample) |
| KR (1) | KR101964479B1 (enExample) |
| CN (1) | CN103459388B (enExample) |
| AU (3) | AU2012233246B2 (enExample) |
| BR (1) | BR112013024957A2 (enExample) |
| CA (1) | CA2830148C (enExample) |
| DK (1) | DK2692728T3 (enExample) |
| ES (1) | ES2687450T3 (enExample) |
| MX (1) | MX344474B (enExample) |
| WO (1) | WO2012133802A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8742113B2 (en) | 2011-03-31 | 2014-06-03 | Sbi Biotech Co., Ltd. | Furanone derivative |
| JP6569908B2 (ja) * | 2014-01-31 | 2019-09-04 | カルナバイオサイエンス株式会社 | 抗がん剤組成物 |
| CN104744353B (zh) * | 2015-03-31 | 2017-11-24 | 山东友帮生化科技有限公司 | 2‑氨基‑3‑碘‑5‑氯吡啶的合成方法 |
| AU2017354372A1 (en) * | 2016-11-04 | 2019-06-20 | Carna Biosciences, Inc. | Furanone derivates and methods of use thereof |
| GB201807147D0 (en) | 2018-05-01 | 2018-06-13 | Oncologica Uk Ltd | Therapeutic combination |
| US12533353B2 (en) * | 2018-09-24 | 2026-01-27 | Carna Biosciences, Inc. | Methods of treatment of cancer comprising CDC7 inhibitors |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6987113B2 (en) | 1997-06-11 | 2006-01-17 | Sugen, Inc. | Tyrosine kinase inhibitors |
| US6335342B1 (en) | 2000-06-19 | 2002-01-01 | Pharmacia & Upjohn S.P.A. | Azaindole derivatives, process for their preparation, and their use as antitumor agents |
| JP2006501191A (ja) | 2002-07-17 | 2006-01-12 | ファルマシア・イタリア・エス・ピー・エー | キナーゼ阻害剤としてのヘテロ二環式ピラゾール誘導体 |
| US20050137220A1 (en) | 2003-07-23 | 2005-06-23 | Pharmacia Corporation | Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors |
| DE602004014163D1 (de) | 2003-08-08 | 2008-07-10 | Pfizer Italia Srl | Pyrimidylpyrrolderivate, die als kinaseinhibitoren wirken |
| US20050043346A1 (en) | 2003-08-08 | 2005-02-24 | Pharmacia Italia S.P.A. | Pyridylpyrrole derivatives active as kinase inhibitors |
| FR2876103B1 (fr) | 2004-10-01 | 2008-02-22 | Aventis Pharma Sa | Nouveaux derives bis-azaindoles, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases |
| AU2005293831B2 (en) * | 2004-10-14 | 2011-01-06 | F. Hoffmann-La Roche Ag | Novel Azaindole thiazolinones as anti-cancer agents |
| US20060122232A1 (en) * | 2004-12-06 | 2006-06-08 | Development Center For Biotechnology | 4-Hydroxyfuroic acid derivatives |
| US7371862B2 (en) * | 2005-11-11 | 2008-05-13 | Pfizer Italia S.R.L. | Azaindolylidene derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| KR20090008286A (ko) | 2006-03-27 | 2009-01-21 | 네르비아노 메디칼 사이언시스 에스.알.엘. | 키나제 억제제로서의 피리딜- 및 피리미디닐-치환된 피롤-,티오펜- 및 푸란- 유도체 |
| FR2907120B1 (fr) | 2006-10-12 | 2013-01-11 | Sanofi Aventis | Nouveaux derives imidazolones,leur preparation a titre de medicaments,compositions pharmaceutiques,utilisation comme inhibiteurs de proteines kinases notamment cdc7 |
| WO2008109443A2 (en) | 2007-03-02 | 2008-09-12 | Mdrna, Inc. | Nucleic acid compounds for inhibiting cdk2 gene expression and uses thereof |
| WO2009155052A1 (en) | 2008-05-28 | 2009-12-23 | Wyeth | 3-substituted-1h-pyrrolo[2,3-b]pyridine and 3-substituted-1h-pyrrolo[3,2-b]pyridine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| WO2010030727A1 (en) * | 2008-09-10 | 2010-03-18 | Wyeth Llc | 3-substituted-1h-indole, 3-substituted-1h-pyrrolo[2,3-b]pyridine and 3-substituted-1h-pyrrolo[3,2-b]pyridine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| CA2767089A1 (en) | 2009-07-15 | 2011-01-20 | Abbott Laboratories | Pyrrolopyridine inhibitors of kinases |
| TW201127384A (en) | 2009-11-18 | 2011-08-16 | Nerviano Medical Sciences Srl | Therapeutic combination comprising a Cdc7 inhibitor and an antineoplastic agent |
| US20120135989A1 (en) | 2010-06-29 | 2012-05-31 | Crystalgenomics, Inc. | Azaindole derivative |
| US8742113B2 (en) | 2011-03-31 | 2014-06-03 | Sbi Biotech Co., Ltd. | Furanone derivative |
| JP6569908B2 (ja) | 2014-01-31 | 2019-09-04 | カルナバイオサイエンス株式会社 | 抗がん剤組成物 |
-
2012
- 2012-03-30 US US14/008,488 patent/US8742113B2/en not_active Ceased
- 2012-03-30 JP JP2013507805A patent/JP5659356B2/ja active Active
- 2012-03-30 CA CA2830148A patent/CA2830148C/en active Active
- 2012-03-30 AU AU2012233246A patent/AU2012233246B2/en active Active
- 2012-03-30 EP EP12763979.7A patent/EP2692728B1/en active Active
- 2012-03-30 DK DK12763979.7T patent/DK2692728T3/en active
- 2012-03-30 ES ES12763979.7T patent/ES2687450T3/es active Active
- 2012-03-30 WO PCT/JP2012/058636 patent/WO2012133802A1/ja not_active Ceased
- 2012-03-30 BR BR112013024957A patent/BR112013024957A2/pt not_active IP Right Cessation
- 2012-03-30 US US15/172,021 patent/USRE46815E1/en active Active
- 2012-03-30 MX MX2013010962A patent/MX344474B/es active IP Right Grant
- 2012-03-30 CN CN201280015870.5A patent/CN103459388B/zh active Active
- 2012-03-30 US US15/967,323 patent/USRE48140E1/en active Active
- 2012-03-30 KR KR1020137028226A patent/KR101964479B1/ko active Active
-
2014
- 2014-10-28 JP JP2014219074A patent/JP5891576B2/ja active Active
-
2016
- 2016-02-05 JP JP2016020407A patent/JP6256927B2/ja active Active
-
2017
- 2017-06-13 AU AU2017203986A patent/AU2017203986B2/en active Active
-
2019
- 2019-05-17 AU AU2019203483A patent/AU2019203483A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017008120A5 (enExample) | ||
| JP2012107057A5 (enExample) | ||
| JP2015522045A5 (enExample) | ||
| JP2013173781A5 (enExample) | ||
| JP2017514877A5 (enExample) | ||
| JP2018536572A5 (enExample) | ||
| JP2014221779A5 (enExample) | ||
| JP2013173782A5 (enExample) | ||
| JP2013532130A5 (enExample) | ||
| JP2015053053A5 (enExample) | ||
| JP2016530351A5 (enExample) | ||
| JP2015125255A5 (enExample) | ||
| JP2015042663A5 (enExample) | ||
| JP2014235432A5 (enExample) | ||
| JP2016535100A5 (enExample) | ||
| JP2020528637A5 (enExample) | ||
| JP2015501646A5 (enExample) | ||
| EA201790432A1 (ru) | Зонды для визуализации белка хантингтина | |
| JP2015199738A5 (enExample) | ||
| JP2019503884A5 (enExample) | ||
| ZA201608442B (en) | Methods for the preparation of 1,3-benzodioxole heterocyclic compounds | |
| DK3722284T3 (da) | 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4,5]-decan-derivater | |
| JP2015016294A5 (enExample) | ||
| UY4430S (es) | “motocicleta”. | |
| NZ732704A (en) | Quinoline carboxamides for use in the treatment of leukemia |